Longevity Medicine, Functional Wellness & Anti-Aging Insights from HormoneSynergy®

Detox foot baths, ionic cleanses, and many modern “detox” products are often marketed using fear, pseudoscience, and exaggerated claims. In longevity medicine, it is important to separate legitimate recovery and stress reduction practices from wellness theater and predatory wellness marketing.

Wellness retreats and meditation practices can support stress reduction, sleep, emotional resilience, and healthier habits. But some wellness programs drift into exaggerated claims, fear-based marketing, and predatory wellness. Here is how to separate useful practices from wellness grifting.

Preventive medicine should not require ideological alignment. Sleep, metabolic health, cardiovascular risk, nutrition, body composition, and recovery physiology are not political positions. In longevity medicine, the goal is not wellness tribalism or internet certainty. The goal is disciplined clinical thinking applied earlier and more thoughtfully.

Brain health is influenced by far more than memory supplements or genetics. Diet patterns affect insulin signaling, inflammation, vascular health, gut-brain communication, sleep quality, and cognitive resilience over time. In longevity medicine, nutrition is viewed as one part of a larger brain-health system.

Testosterone therapy for women is not a new conversation in longevity medicine. While recent FDA discussions have brought needed attention to the lack of FDA-approved testosterone products specifically labeled for women, Dr. Kathryn Retzler has been prescribing, teaching, and lecturing on hormone therapy for women and men for more than 25 years.

Many people with “normal” fasting glucose may still experience abnormal blood sugar spikes after meals. Postprandial glucose dysregulation is increasingly recognized as an early sign of metabolic dysfunction, insulin resistance, and reduced metabolic flexibility long before diabetes develops.

Rates of colorectal cancer are rising in younger adults, and emerging research suggests that modifiable risk factors including metabolic dysfunction, obesity, inflammation, microbiome disruption, antibiotic exposure, and lifestyle patterns may play an important role. This HormoneSynergy® Longevity Medicine article explores the growing conversation around early-onset colon cancer from a systems biology and prevention-focused perspective.

A recent headline claimed GLP-1 medications like Ozempic® may reduce the risk of death after breast cancer by 91%. The number is dramatic, but the actual study raises important questions about observational data, metabolic health, obesity, inflammation, and what longevity medicine should, and should not,  conclude from early research.

The conversation around ovarian longevity, menopause, and hormone therapy is evolving. In 2025, the FDA announced major changes to long-standing boxed warnings on many menopausal hormone therapy products, reflecting a more nuanced understanding of risks, timing, and individualized care. At HormoneSynergy®, these conversations have been part of evidence-based longevity medicine for decades.

A growing body of research suggests that a large percentage of cancer risk is connected to modifiable factors including metabolic health, inflammation, visceral fat, alcohol, smoking, sleep, physical activity, and environmental exposures. Preventive longevity medicine focuses on improving the underlying physiology that influences long-term disease risk rather than chasing “miracle” prevention strategies.

Microplastics are becoming a legitimate environmental and health concern, but many online claims move faster than the science. Here is the practical middle ground through a longevity medicine lens.

Continuous glucose monitors are increasingly criticized as unnecessary for “healthy” people. But many individuals considered healthy by standard testing may already show early metabolic dysfunction long before diabetes develops. HormoneSynergy® explores where CGMs may provide meaningful insight, where the marketing goes too far, and why preventive longevity medicine often focuses on trajectory before diagnosis.